The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

The Medical College of Wisconsin created a neurology department 50 years ago. Today with Froedtert it is world leader in ...

“There are a total of 93 products in Phase I-III development within the 7MM for the treatment of Parkinson’s,” Palmer said. “66% of these are prospective neuroprotective agents or DMT ...

Parkinson’s treatment and management. People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital ...

Thus, another clinical candidate in its pipeline would be Risvodetinib [IKT-148009] for the treatment of patients with Parkinson's Disease [PD]. The use of this kinase inhibitor is being explored ...

with often ineffective treatment options. Deep brain stimulation (DBS) is already being used to treat physical symptoms—such as tremors—in people living with Parkinson's. But, until now ...

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

Parkinson's disease, a neurological disorder best known ... the brain important for learning and memory," Bernard said. After treatment with PNA5, researchers watched blood levels of the ...

a-syn is believed to be a key protein in the disease due to its high prevalence in patients with Parkinson's disease. Treatment with ACI-7104.056 induced an increase in anti-a-syn antibodies on ...